Cited by 286Alzheimer's disease research and treatmentsProtease and Inhibitor MechanismsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.

Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity

Open access

White, Anthony R., Du, Tai, Laughton, Katrina M., Volitakis, Irene, Sharples, Robyn A., Xilinas, Michel E., Hoke, David E., Holsinger, R. M. Damian, Evin, Geneviève, Cherny, Robert A., Hill, Andrew F., Barnham, Kevin J., Li, Qiao-Xin, Bush, Ashley I., Masters, Colin L.·2006·Journal of Biological Chemistry

DOI 10.1074/jbc.m602487200

Open this paper in CoChat — free account Open PDF

Abstract

Biometals play an important role in Alzheimer disease, and recent reports have described the development of potential therapeutic agents based on modulation of metal bioavailability. The metal ligand clioquinol (CQ) has shown promising results in animal models and small phase clinical trials; however, the actual mode of action in vivo has not been determined. We now report a novel effect of CQ on amyloid β-peptide (Aβ) metabolism in cell culture. Treatment of Chinese hamster ovary cells overexpressing amyloid precursor protein with CQ and Cu 2+ or Zn 2+ resulted in an ∼85–90% reduction of secreted Aβ-(1–40) and Aβ-(1–42) compared with untreated controls. Analogous effects were seen in amyloid precursor protein-overexpressing neuroblastoma cells. The secreted Aβ was rapidly degraded through up-regulation of matrix metalloprotease (MMP)-2 and MMP-3 after addition of CQ and Cu 2+ . MMP activity was increased through activation of phosphoinositol 3-kinase and JNK. CQ and Cu 2+ also promoted phosphorylation of glycogen synthase kinase-3, and this potentiated activation of JNK and loss of Aβ-(1–40). Our findings identify an alternative mechanism of action for CQ in the reduction of Aβ deposition in the brains of CQ-treated animals and potentially in Alzheimer disease patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1074/jbc.m602487200

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Self-citation
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683
Self-citation
The neurobiology of zinc in health and disease
Frederickson, C. J., Koh, J., & Bush, A. I. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1671 · Cited by 1,841
Self-citation
Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447
Self-citation
The metallobiology of Alzheimer's disease
Bush, A. I. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00067-5 · Cited by 1,315
Self-citation
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
Phiel, C. J., Wilson, C., Lee, V. M. ‐., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,211
Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease: A Pilot Phase 2 Clinical Trial
Ritchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988
Self-citation
Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression
Liang, J., & Slingerland, J. M. (2003) · Cell Cycle · doi:10.4161/cc.2.4.433 · Cited by 885
Enhanced Proteolysis of β-Amyloid in APP Transgenic Mice Prevents Plaque Formation, Secondary Pathology, and Premature Death
Leissring, M. A., Farris, W., Chang, A. Y., Walsh, D. M., Wu, X., Sun, X., Frosch, M. P., & Selkoe, D. J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00787-6 · Cited by 725
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620
Self-citation

Flagged first, then by citations

Show all 44 references

1 of the 44 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

Miyata, 2004, Mol. Cancer Ther., 3, 839
Wu, 1999, Am. J. Physiol., 277, L924

Sorted by citations

Items 201–286 of 286

Subcellular localization of a fluorescent derivative of CuII(atsm) offers insight into the neuroprotective action of CuII(atsm)
Price, K. A., Crouch, P. J., Lim, S., Paterson, B. M., Liddell, J. R., Donnelly, P. S., & White, A. R. (2011) · Metallomics · doi:10.1039/c1mt00092f · Cited by 20
Self-citation
Metal ion coordination in peptide fragments of neurotrophins: A crucial step for understanding the role and signaling of these proteins in the brain
Mendola, D. L., Arena, G., Pietropaolo, A., Satriano, C., & Rizzarelli, E. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.213790 · Cited by 21
Matrix metalloproteinase 3 haplotypes and plasma amyloid beta levels: The Rotterdam Study
Reitz, C., van Rooij, F. J. A., Soares, H. D., de Maat, M. P. M., Albert Hofman, D., Witteman, J. C. M., & Breteler, M. M. B. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.033 · Cited by 21
Role of Amyloid-β–Metal Interactions In Alzheimer‘s Disease
Duce, J. A., Bush, A. I., & Adlard, P. A. (2011) · Future Neurology · doi:10.2217/fnl.11.43 · Cited by 20
Self-citation
Colorimetric visualization of Cu2+ based on Cu2+-catalyzed reaction and the signal amplification induced by K+-aptamer-Cu2+ complex
Wei, X., Xu, H., Li, W., & Chen, Z. (2016) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2016.10.114 · Cited by 20
Cellular Up-regulation of Nedd4 Family Interacting Protein 1 (Ndfip1) using Low Levels of Bioactive Cobalt Complexes
Schieber, C., Howitt, J. A., Putz, U., White, J. M., Parish, C. L., Donnelly, P. S., & Tan, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.203448 · Cited by 19
Effect of Fluvoxamine on Amyloid-β Peptide Generation and Memory
Kim, W., Fu, Y.-H., Dobson-Stone, C., Hsiao, J.-H. T., Shang, K.-N., Hallupp, M., Schofield, P., Garner, B., Karl, T., & Kwok, J. B. J. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-171001 · Cited by 15
Modulating Metals As A Therapeutic Strategy For Alzheimer’s Disease
Hung, L. W., & Barnham, K. J. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.32 · Cited by 18
Self-citation
An inorganic overview of natural Aβ fragments: Copper(II) and zinc(II)-mediated pathways
Lanza, V., Bellia, F., & Rizzarelli, E. (2018) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.04.004 · Cited by 18
His-Rich Domain of Selenoprotein P Ameliorates Neuropathology and Cognitive Deficits by Regulating TrkB Pathway and Zinc Homeostasis in an Alzheimer Model of Mice
Yue, C., Shan, Z., Tan, Y., Yao, C., Liu, Y., Liu, Q., Tan, X., & Du, X. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00278 · Cited by 18
Solution Chemistry of Copper(II) Binding to Substituted 8‑Hydroxyquinolines
Summers, K. L., Pushie, M. J., Sopasis, G. J., James, A. K., Dolgova, N. V., Sokaras, D., Kröll, T., Harris, H. H., Pickering, I. J., & George, G. N. (2020) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.0c01356 · Cited by 18
Experimental approaches for altering the expression of Abeta‐degrading enzymes
Loeffler, D. A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15762 · Cited by 18
Effects of Multifunctional Antioxidants on Mitochondrial Dysfunction and Amyloid-β Metal Dyshomeostasis
Kawada, H., Blessing, K., Kiyota, T., Woolman, T. A., Winchester, L. C., & Kador, P. F. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-132471 · Cited by 16
Copper Downregulates Neprilysin Activity Through Modulation of Neprilysin Degradation
Li, M., Sun, M., Liu, Y., Yu, J. H., Yang, H., Fan, D., & Chui, D. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1218 · Cited by 17
Chronic Exposure to High Levels of Zinc or Copper has Little Effect on Brain Metal Homeostasis or Aβ Accumulation in Transgenic APP-C100 Mice
Maynard, C. J., Cappai, R., Volitakis, I., Laughton, K. M., Masters, C. L., Bush, A. I., & Li, Q. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9401-7 · Cited by 17
Self-citation
Development of a Sensitive Escherichia coli Bioreporter Without Antibiotic Markers for Detecting Bioavailable Copper in Water Environments
Pang, Y., Ren, X., Li, J., Liang, F., Rao, X., Gao, Y., Wu, W., Li, D., Wang, J., Zhao, J., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03031 · Cited by 16
Zinc Inhibits Amyloid β Production from Alzheimer's Amyloid Precursor Protein in SH-SY5Y Cells
Lee, J., Kim, C. H., Kim, D. G., & Ahn, Y. S. (2009) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2009.13.3.195 · Cited by 16
Mutual Stimulation of Beta-Amyloid Fibrillogenesis by Clioquinol and Divalent Metals
Bolognin, S., Zatta, P. F., Drago, D., Parnigotto, P. P., Ricchelli, F., & Tognon, G. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8046-x · Cited by 16
Mechanism of Metal Complexes in Alzheimer’s Disease
Yi, L. I. U., Ma, J., Zhang, Q., Wang, Y., & Sun, Q. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211873 · Cited by 15
Ionophore Ability of Carnosine and Its Trehalose Conjugate Assists Copper Signal in Triggering Brain-Derived Neurotrophic Factor and Vascular Endothelial Growth Factor Activation In Vitro
Николаевна, Н. И., Greco, V., Sciuto, S., Attanasio, F., & Rizzarelli, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413504 · Cited by 15
Impact of MMP2 rs243865 and MMP3 rs3025058 Polymorphisms on Clinical Findings in Alzheimer’s Disease Patients
Ďurmanová, V., Javor, J., Párnická, Z., Minárik, G., Ocenasova, A., Vašečková, B., Režnáková, V., Kralova, M., Hromádka, T., & Shawkatová, I. (2021) · Mediators of Inflammation · doi:10.1155/2021/5573642 · Cited by 15
Alzheimer′s Disease and Metals: A Review of the Involvement of Cellular Membrane Receptors in Metallosignalling
Amadoruge, P. C., & Barnham, K. J. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/542043 · Cited by 14
Self-citation
Targeting Mitochondrial Metal Dyshomeostasis for the Treatment of Neurodegeneration
Liddell, J. R. (2015) · Neurodegenerative Disease Management · doi:10.2217/nmt.15.19 · Cited by 13
Trace element imbalances in blood serum of Alzheimer’s disease patients
Lavanya, R., Reddy, B. S., Sattar, S. A., & Rao, A. D. P. (2021) · Spectroscopy Letters · doi:10.1080/00387010.2021.1941124 · Cited by 13
Novel Pharmacotherapies for Alzheimer's Disease
Han, S. (2009) · Journal of Korean Medical Association · doi:10.5124/jkma.2009.52.11.1059 · Cited by 11
Three-dimensional endothelial cell morphogenesis under controlled ion release from copper-doped phosphate glass
Stähli, C., James-Bhasin, M., & Nazhat, S. N. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.002 · Cited by 13
Substituted sulfonamide bioisosteres of 8-hydroxyquinoline as zinc-dependent antibacterial compounds
McGowan, J. E., Harper, A. D., Davison, E. K., Jeong, J. Y., Mros, S., Harbison-Price, N., Zuylen, E. M. V., Knottenbelt, M. K., Heikal, A., Ferguson, S. A., et al. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127110 · Cited by 13
Copper Status Abnormalities and How to Measure Them in Neurodegenerative Disorders
Siotto, M., Bucossi, S., & Squitti, R. (2010) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488910793362395 · Cited by 13
Protective effects of clioquinol on human neuronal-like cells: a new formulation of clioquinol-loaded PLGA microspheres for Alzheimer’s disease
Barcia, E., Salama, A., Fernández-Carballido, A. M., & Negro, S. (2010) · Journal of drug targeting · doi:10.3109/1061186x.2010.523789 · Cited by 13
Targeting Metals in Alzheimer’s Disease: An Update
Du, B., Chen, K., Wang, W., & Lei, P. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240140 · Cited by 13
Cell-specific copper dyshomeostasis mechanism in Alzheimer’s disease
Okafor, M., Faller, P., & Vitale, N. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00504-6 · Cited by 16
Copper ion-induced fluorescence band shift of CdTe quantum dots: a highly specific strategy for visual detection of Cu 2+ with a portable UV lamp
Lu, X., Zhao, Y., Zhang, J., Lu, X., Wang, Y., & Liu, C. (2015) · The Analyst · doi:10.1039/c5an01963j · Cited by 12
Matrix metalloproteinase 3 haplotypes and dementia and Alzheimer's disease
Reitz, C., van Rooij, F. J. A., de Maat, M. P. M., den Heijer, T., Albert Hofman, D., Witteman, J. C. M., & Breteler, M. M. B. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.01.001 · Cited by 11
Active uptake of hydrophilic copper complex Cu( ii )–TETA in primary cultures of neonatal rat cardiomyocytes
Fu, C., Lizhao, J., Luo, Z., Wang, T., Grapperhaus, C. A., Ding, X., & Kang, Y. J. (2019) · Metallomics · doi:10.1039/c8mt00277k · Cited by 10
Wild Type and Tangier Disease ABCA1 Mutants Modulate Cellular Amyloid-β Production Independent of Cholesterol Efflux Activity
Kim, W. S., Hill, A. F., Fitzgerald, M. L., Freeman, M. W., Evin, G. M., & Garner, B. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110521 · Cited by 10
Self-citation
Aluminum does not enhance β-amyloid toxicity in rat hippocampal cultures
Nday, C. M., Drever, B. D., Salifoglou, T., & Platt, B. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.008 · Cited by 10
Matrix metalloproteinases and tissue inhibitors of metalloproteinases as the biomarkers of Alzheimer’s disease: A meta-analysis
Mak, K. K., Nam, J. K., Chuang, Y., & Chen, L. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149954 · Cited by 10
Natural compounds attenuate heavy metal-induced PC12 cell damage
Yang, L., Shen, K., & Ji, D. (2020) · Journal of International Medical Research · doi:10.1177/0300060520930847 · Cited by 9
New BDNF and NT-3 Cyclic Mimetics Concur with Copper to Activate Trophic Signaling Pathways as Potential Molecular Entities to Protect Old Brains from Neurodegeneration
Magrì, A. L., Tomasello, B., Николаевна, Н. И., Tabbı̀, G., Cairns, W. R. L., Greco, V., Sciuto, S., Mendola, D. L., & Rizzarelli, E. (2024) · Biomolecules · doi:10.3390/biom14091104 · Cited by 9
Surface Trafficking of APP and BACE in Live Cells
Bauereiss, A., Welzel, O., Jung, J., Grosse‐Holz, S., Lelental, N., Lewczuk, P., Wenzel, E. M., Kornhuber, J., & Groemer, T. W. (2015) · Traffic · doi:10.1111/tra.12270 · Cited by 9
The anti-neurodegenerative agent clioquinol regulates the transcription factor FOXO1a
Cameron, A., Wallace, K. S., Logie, L., Prescott, A. R., Unterman, T. G., Harthill, J. E., & Rena, G. (2012) · Biochemical Journal · doi:10.1042/bj20112124 · Cited by 9
Molecular Determinants of Alzheimer’s Disease Aβ Peptide Neurotoxicity
Cappai, R., & Barnham, K. J. (2007) · Future Neurology · doi:10.2217/14796708.2.4.397 · Cited by 9
Self-citation
Towards a Cure for Dementia: The Role of Axonal Transport in Alzheimer's Disease
Wilson, R. J. (2008) · Science Progress · doi:10.3184/003685008x285375 · Cited by 9
A novel rhamnoside derivative PL402 up-regulates matrix metalloproteinase 3/9 to promote Aβ degradation and alleviates Alzheimer’s-like pathology
Hu, T., Zhou, Y., Lu, J. N., Xia, P., Chen, Y., Cao, X., & Pei, G. (2020) · Aging · doi:10.18632/aging.102637 · Cited by 8
α-Lipoic acid: a potential regulator of copper metabolism in Alzheimer’s disease
Kirss, S., Reinapu, A., Kabin, E., Smirnova, J., Tõugu, V., & Palumaa, P. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1451536 · Cited by 7
The Role of Metals in Alzheimer’s Disease
Hajji, N., Calvert, C., Ritchie, C. W., & Sastre, M. (2013) · Royal Society of Chemistry eBooks · doi:10.1039/9781849735896-00080 · Cited by 7
MMP2 rs243866 and rs2285053 Polymorphisms and Alzheimer’s Disease Risk in Slovak Caucasian Population
Ocenasova, A., Shawkatová, I., Javor, J., Párnická, Z., Minárik, G., Kralova, M., Kiralyova, I., Mikolášková, I., & Ďurmanová, V. (2023) · Life · doi:10.3390/life13040882 · Cited by 8
Serum level of MMP-2, MMP-9 and Ox-LDL in Alzheimer's disease with hyperlipoidemia
Cai, Z., Yan, Y., Yan, L., Wang, F., Huang, H., Wang, Y.-L., & Zhao, Y. C. (2007) · 中国人民解放军军医大学学报：英文版 · doi:10.1016/s1000-1948(08)60017-9 · Cited by 8
Cyclic cis-Locked Phospho-Dipeptides Reduce Entry of AβPP into Amyloidogenic Processing Pathway
Fisher, C. L., Resnick, R. J., De, S., Acevedo, L. A., Lu, K. P., Schroeder, F. C., & Nicholson, L. K. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160051 · Cited by 10
Clinical Trials and Drug Development
Mahipal, A. (2014) · Cancer Control · doi:10.1177/107327481402100301 · Cited by 8
The Role of Glycogen Synthase Kinase 3 in the Mechanisms of Learning and Memory
Grigoryan, G. A. (2014) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-014-0023-2 · Cited by 6
Copper in Brain and Neurodegeneration
Liddell, J. R., Bush, A. I., & White, A. R. (2004) · Encyclopedia of Inorganic and Bioinorganic Chemistry · doi:10.1002/9781119951438.eibc2143 · Cited by 5
Self-citation
Zinc in Autism
Grabrucker, S., & Grabrucker, A. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804562-6.00009-9 · Cited by 4
Membrane‐targeted strategies for modulating APP and Aβ‐mediated toxicity
Price, K. A., Crouch, P. J., Donnelly, P. S., Masters, C. L., White, A. R., & Curtain, C. C. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00642.x · Cited by 4
Self-citation
Aspartate aminotransferase is potently inhibited by copper complexes: Exploring copper complex-binding proteome
Jia, Y.-Q., Lu, L., Yuan, C., Feng, S., & Zhu, M. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.02.011 · Cited by 4
Hybrid Antioxidant and Metal Sequestering Small Molecules Targeting the Molecular Features of Alzheimer’s Disease
Green, K. N., Johnston, H. M., Burnett, M. E., & Brewer, S. M. (2016) · Comments on Inorganic Chemistry · doi:10.1080/02603594.2016.1241616 · Cited by 3
Alzheimer Hastalığı ve Anti-Alzheimer Etkili Bileşiklerin Yapılarının Araştırılması
Tari, O., & YAĞMURTAŞAN, R. (2023) · Hacettepe University Journal of the Faculty of Pharmacy · doi:10.52794/hujpharm.1175099 · Cited by 3
Impaired cellular copper regulation in the presence of ApoE4
Blades, B., Hung, Y. H., Belaidi, A. A., Volitakis, I., Schultz, A. G., Cater, M. A., Cheung, N. S., Bush, A. I., Ayton, S., & Fontaine, S. L. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16198 · Cited by 3
Self-citation
Role of Glycogen Synthase Kinase-3 in Mechanisms of Learning and Memory
Grigoryan, G. A. (2013) · Журнал высшей нервной деятельности им И П Павлова · doi:10.7868/s0044467713050043 · Cited by 3
C-2 derivatized 8-sulfonamidoquinolines as antibacterial compounds
Davison, E. K., McGowan, J. E., Li, F. F., Harper, A. D., Jeong, J. Y., Mros, S., Harbison-Price, N., Zuylen, E. M. V., Knottenbelt, M. K., Heikal, A., et al. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115837 · Cited by 3
Proteolytic remodelling of the extracellular matrix by pericytes
Burkhard, T., Milne, E., Qian, K., Campagnolo, P., & Santamaria, S. (2026) · FEBS Journal · doi:10.1111/febs.70569 · Cited by 2
Elucidating the Role of Metals in Alzheimer’s Disease Through the Use of Surface-Enhanced Laser Desorption/Ionisation Time-of-Flight Mass Spectrometry
Watt, A. D., Perez, K. A., & Hung, L. W. (2011) · Methods in molecular biology · doi:10.1007/978-1-60327-223-0_15 · Cited by 2
Metal Complexing Agents for the Treatment of Alzheimer's Disease
White, A. R., & Bush, A. I. (2007) · Springer eBooks · doi:10.1007/7355_2007_011 · Cited by 2
Self-citation
Role of Metals in Alzheimer Disease
Roberts, B. R., & Bush, A. I. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch24 · Cited by 2
Self-citation
Metals Involvement in Alzheimer’s Disease Pathogenesis
Squitti, R., & Salustri, C. (2011) · InTech eBooks · doi:10.5772/16880 · Cited by 1
Novel Zinc-Targeted Therapeutic Options for Cognitive Decline
Portbury, S. D., Yévenes, L. F., & Adlard, P. A. (2015) · Future Neurology · doi:10.2217/fnl.15.40 · Cited by 1
Copper metabolism and copper-mediated alterations in the metabolism of cultured astrocytes
Scheiber, I. F. (2012) · State and University Library Bremen · Cited by 1
Dual-action peptide shuttles prevent Cu-amyloid-β-induced neurotoxicity and relocate Cu intracellularly
Okafor, M., Schmitt, D., Falcone, E., Gasman, S., Raibaut, L., Hureau, C., Faller, P., & Vitale, N. (2026) · Inorganic Chemistry Frontiers · doi:10.1039/d6qi00862c · Cited by 1
Copper and Alzheimer Disease: The Good, the Bad and the Ugly
Hung, Y. H., Bush, A. I., & Cherny, R. A. (2012) · Springer eBooks · doi:10.1007/978-1-4419-9663-3_30 · Cited by 1
Self-citation
Synthesis of Dimebon and of its Tetrathiomolybdate
Goel, O. P., & Dembiński, R. (2015) · Organic Preparations and Procedures International · doi:10.1080/00304948.2015.1025017 · Cited by 1
The Involvement of Metal Ions in Copper-Zinc Superoxide Dismutase Related Amyotrophic Lateral Sclerosis
Bourassa, M. W. (2012) · Academic Commons (Stony Brook University) · Cited by 1
Natural Phenolics and Metal Metabolism in Neurodegenerative Diseases
Zhao, B. (2009) · Wiley eBooks · doi:10.1002/9780470531792.ch19
Simulating the kinesin walk : towards a definitive theory
Wilson, R. J. (2026) · Warwick Research Archive Portal (University of Warwick) · doi:10.82444/warw.33673393
Part I: Investigation of mechanism(s) of Cu(II) and Zn(II) neurotoxicity Part II: Pre-steady state kinetics of the reduction of cytochrome b561 with ascorbate
Kollalpitiya, K. Y. (2011) · Holmes Museum Of Anthropology (Wichita State University)
Brain zinc metabolism and Alzheimer's disease
Zheng, W., & Zhan-you, W. (2012)
Ileum Proteomics Identifies Distinct Pathways Associated with Different Dietary Doses of Copper–Fructose Interactions: Implications for the Gut–Liver Axis and MASLD
Xu, M., Li, M., Benz, F. W., Merchant, M. L., McClain, C. J., & Song, M. (2024) · Nutrients · doi:10.3390/nu16132083
Alzheimer’s Disease
Ikezu, T. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_22
Scouting Biomarkers for Alzheimer’s Disease via Network Analysis of Exosome Proteomics Data
Sagonas, A., Apostolakou, A. E., Litou, Z. I., Antonelou, M. H., & Iconomidou, V. A. (2025) · BioMedInformatics · doi:10.3390/biomedinformatics5020019
Molecular mechanisms of action of MT-MMPs involved in the pathogenesis of Alzheimer’s disease
García‐González, L. (2020) · theses.fr (ABES) · doi:10.70675/a04672c0z1f4az472ezbcd5zbea446eac50c
MT5-MMP promotes neuroinflammation, pathogenic processing of amyloid precursor protein and synaptic dysfunction at early stages in an Alzheimer's disease model
Piłat, D. (2021) · theses.fr (ABES) · doi:10.70675/0050afedz3f0bz461fzafefz4b4742f76a57
In vitro and in vivo inhibition of amyloid β aggregation by a Ru( ii )–naphthalene diimide complex
Tiburcio, M. A., Cali, M. P., Pereira, L. M. B., Graminha, A. E., Atienza‐Navarro, I., Vendruscolo, M., Garcı́a-Alloza, M., & Carlos, R. M. (2026) · Dalton Transactions · doi:10.1039/d5dt02853a
Correlation between MMP-3-1171 5A/6A polymorphism and the risk of Alzheimer’s disease
Wang, Y., Zhu, S., Ma, Y., Chen, X., & Zhou, M. (2026) · Medicine · doi:10.1097/md.0000000000050560
BindingDB Entry 50011295: Matrix Metalloproteinases as New Targets in Alzheimer's Disease: Opportunities and Challenges.
BindingDB (2022) · UC San Diego · doi:10.7270/q2bv7m7k
BindingDB Entry 3592: Site-activated chelators targeting acetylcholinesterase and monoamine oxidase for Alzheimer's therapy.
BindingDB (2011) · UC San Diego · doi:10.7270/q2959fx1
Amyloid precursor protein (APP) and copper homeostasis in the human neuroblastoma cell line SH-SY5Y
Klein, J. (2011)
The molecular basis of the interactions of copper metallochaperones
Aggarwal, S. (2011)

Authors: White, A. R., Du, T., Laughton, K. M., Volitakis, I., Sharples, R. A., Xilinas, M. E., Hoke, D. E., Holsinger, R. M. D., Evin, G., Cherny, R. A., Hill, A. F., Barnham, K. J., Li, Q.-X., Bush, A. I., & Masters, C. L.
Affiliations: Mental Health Research Institute (AU)
Corresponding author: White, Anthony R.
ORCID: White, Anthony R.
Volitakis, Irene
Hoke, David E.
Holsinger, R. M. Damian
Hill, Andrew F.
Barnham, Kevin J.
Li, Qiao-Xin
Bush, Ashley I.
Masters, Colin L.
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 2006-06
Volume: 281
Issue: 26
Pages: 17670-17680
ISSN: 0021-9258 (ISSN-L)
DOI: 10.1074/jbc.m602487200
OpenAlex: W2131181742
Cited by: 284
References: 44
Citations by year: 2026: 5 · 2025: 3 · 2024: 10 · 2023: 6 · 2022: 4 · 2021: 10 · 2020: 17 · 2019: 5 · 2018: 6 · 2017: 11 · 2016: 13 · 2015: 18 · 2014: 16 · 2013: 12 · 2012: 21
FWCI: 16.39
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 5226 d)
Locations: Journal of Biological Chemistry (publishedVersion, cc-by)
Victoria University Research Repository (Victoria University) (submittedVersion, cc-by)
Funders: National Institute on Aging (R01-AG12686, AG 05887)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: Alzheimer's disease, amyloid-beta, clioquinol, MMP-2, MMP-3, copper, zinc, amyloid precursor protein, phosphatidylinositol 3-kinase, JNK, glycogen synthase kinase-3, metal bioavailability, biometals

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks